Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis

Gerard Socié,Dietger Niederwieser,Nikolas von Bubnoff,Mohamad Mohty,Jeff Szer,Reuven Or,James Garrett,Anirudh Prahallad,Celine Wilke,Robert Zeiser

Blood（2023）

引用 1|浏览5

暂无评分

摘要

•Low levels of most aGVHDs (before/after treatment) and immune cell markers (before treatment) positively affect the probability of response.•Models (baseline and day 14) can help identify patient characteristics and biomarkers for improved response to ruxolitinib vs BAT.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要